Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts – a multi-stakeholder consensus view for a practical approach in Germany

R. Schultz-Heienbrok, S. Baumann, R. Böhm, A. Bonertz, K. Breithaupt-Groegler, U. Buckpesch-Heberer, M. Coenen, K. Erb-Zohar, N. Faisst, G. Grass, J. Höchel, A. Kovar, A. Muehlenbroich, J. Rengelshausen, C. Riedel, B. Schug, T. Sudhop, A. Warnke, B. Ziegele

Open source

DOI: 10.3389/fphar.2026.1948963
Published: 2026-09-02
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1948963,
  title = {Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts – a multi-stakeholder consensus view for a practical approach in Germany},
  author = {R. Schultz-Heienbrok and S. Baumann and R. Böhm and A. Bonertz and K. Breithaupt-Groegler and U. Buckpesch-Heberer and M. Coenen and K. Erb-Zohar and N. Faisst and G. Grass and J. Höchel and A. Kovar and A. Muehlenbroich and J. Rengelshausen and C. Riedel and B. Schug and T. Sudhop and A. Warnke and B. Ziegele},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1948963},
  url = {https://doi.org/10.3389/fphar.2026.1948963}
}

RIS

TY  - JOUR
TI  - Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts – a multi-stakeholder consensus view for a practical approach in Germany
AU  - R. Schultz-Heienbrok
AU  - S. Baumann
AU  - R. Böhm
AU  - A. Bonertz
AU  - K. Breithaupt-Groegler
AU  - U. Buckpesch-Heberer
AU  - M. Coenen
AU  - K. Erb-Zohar
AU  - N. Faisst
AU  - G. Grass
AU  - J. Höchel
AU  - A. Kovar
AU  - A. Muehlenbroich
AU  - J. Rengelshausen
AU  - C. Riedel
AU  - B. Schug
AU  - T. Sudhop
AU  - A. Warnke
AU  - B. Ziegele
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1948963
UR  - https://doi.org/10.3389/fphar.2026.1948963
ER  -

APA

Schultz-Heienbrok, R., Baumann, S., Böhm, R., Bonertz, A., Breithaupt-Groegler, K., Buckpesch-Heberer, U., Coenen, M., Erb-Zohar, K., Faisst, N., Grass, G., Höchel, J., Kovar, A., Muehlenbroich, A., Rengelshausen, J., Riedel, C., Schug, B., Sudhop, T., Warnke, A., & Ziegele, B. (2026). Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts – a multi-stakeholder consensus view for a practical approach in Germany. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1948963

Source records

crossref · retrieved 2026-09-26T04:39:57.696Z